Edwards Lifesciences Corp (USD)
EW
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryMedical Devices
Day Range225.13 | 229.88
52-Wk Range136.44 | 230.19
Last Close227.11
Mkt Cap (m)47,231.89
Dividend yield-
ISINUS28176E1082
Volume338,401
Exchange VenueNYS

Company Profile

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.

Key Information
Price/Earning66.41
Price/Book13.50
Price/Sales12.17
P/CF49.32
Rev Growth (3 year avg)14.29
EPS Growth (3 year avg)0.15
Operating Margin % 28.81
Net Margin %19.40
Return on Equity23.69
Debt/Equity0.19

Legal Documents

Prospectus
en 07/06/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)2,0462,3232,4942,9643,4353,723
Operating Income (m)4554836437841,0231,073
Net Income (m)392811495570584722
Basic EPS1.763.812.302.672.773.45
Avg. Diluted Shares Outstanding (m)228217220218216214
Balance Sheet
USD201320142015201620172018
Current Assets (m)1,7262,2952,0482,2402,5322,287
Non Current Assets (m)9991,2302,0112,2703,1643,037
Total Assets (m)2,7253,5244,0594,5105,6965,324
Current Liabilities (m)3464344765331,403877
Total Liabilities (m)------
Total Equity (m)1,5592,1912,5032,6192,9563,140
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)4731,0225507041,001927
Capital Expenditure (m)-110-94-107-217-176-242
Figures are quoted in USD unless stated otherwise
-0.66 (-0.29%)
$
226.45
Last Price